• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于多孔二氧化硅的二硫键抗氧化剂新型口服制剂的研发,用于药物的控释。

Development of Novel Oral Formulations of Disulfide Antioxidants Based on Porous Silica for Controlled Release of the Drugs.

作者信息

Dolinina Ekaterina S, Parfenyuk Elena V

机构信息

Laboratory "Chemistry of Hybrid Nanomaterials and Supramolecular Systems", G.A. Krestov Institute of Solution Chemistry of Russian Academy of Sciences, 153045 Ivanovo, Russia.

出版信息

Materials (Basel). 2021 Feb 18;14(4):963. doi: 10.3390/ma14040963.

DOI:10.3390/ma14040963
PMID:33670671
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7923038/
Abstract

Powerful antioxidant α-lipoic acid (LA) exhibits limited therapeutic efficiency due to its pharmacokinetic properties. Therefore, the purpose of this work was to evaluate the ability of silica-based composites of LA as well as its amide (lipoamide, LM), as new oral drug formulations, to control their release and maintain their therapeutic concentration and antioxidant activity in the body over a long time. The composites synthesized at different sol-gel synthesis pH and based on silica matrixes with various surface chemistry were investigated. The release behavior of the composites in media mimicking pH of digestive fluids (pH 1.6, 6.8, and 7.4) was revealed. The effects of chemical structure of the antioxidants, synthesis pH, surface chemistry of the silica matrixes in the composites as well as the pH of release medium on kinetic parameters of the drug release and mechanisms of the process were discussed. The comparative analysis of the obtained data allowed the determination of the most promising composites. Using these composites, modeling of the release process of the antioxidants in accordance with transit conditions of the drugs in stomach, proximal, and distal parts of small intestine and colon was carried out. The composites exhibited the release close to the zero order kinetics and maintained the therapeutic concentration of the drugs and antioxidant effect in all parts of the intestine for up to 24 h. The obtained results showed that encapsulation of LA and LM in the silica matrixes is a promising way to improve their bioavailability and antioxidant activity.

摘要

强大的抗氧化剂α-硫辛酸(LA)由于其药代动力学特性,治疗效率有限。因此,本研究的目的是评估基于二氧化硅的LA复合材料及其酰胺(硫辛酰胺,LM)作为新型口服药物制剂,在长时间内控制其释放并维持其在体内的治疗浓度和抗氧化活性的能力。研究了在不同溶胶-凝胶合成pH值下合成的、基于具有不同表面化学性质的二氧化硅基质的复合材料。揭示了复合材料在模拟消化液pH值(pH 1.6、6.8和7.4)的介质中的释放行为。讨论了抗氧化剂的化学结构、合成pH值、复合材料中二氧化硅基质的表面化学性质以及释放介质的pH值对药物释放动力学参数和过程机制的影响。通过对所得数据的比较分析,确定了最有前景的复合材料。使用这些复合材料,根据药物在胃、小肠近端和远端以及结肠中的转运条件,对抗氧化剂的释放过程进行了建模。复合材料表现出接近零级动力学的释放,并在肠道所有部位维持药物的治疗浓度和抗氧化作用长达24小时。所得结果表明,将LA和LM包裹在二氧化硅基质中是提高其生物利用度和抗氧化活性的一种有前景的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0e0/7923038/b420deede0be/materials-14-00963-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0e0/7923038/63fcc3c10aa8/materials-14-00963-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0e0/7923038/117f16f05f62/materials-14-00963-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0e0/7923038/07ca51a97870/materials-14-00963-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0e0/7923038/faf700b3868b/materials-14-00963-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0e0/7923038/b420deede0be/materials-14-00963-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0e0/7923038/63fcc3c10aa8/materials-14-00963-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0e0/7923038/117f16f05f62/materials-14-00963-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0e0/7923038/07ca51a97870/materials-14-00963-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0e0/7923038/faf700b3868b/materials-14-00963-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0e0/7923038/b420deede0be/materials-14-00963-g005.jpg

相似文献

1
Development of Novel Oral Formulations of Disulfide Antioxidants Based on Porous Silica for Controlled Release of the Drugs.基于多孔二氧化硅的二硫键抗氧化剂新型口服制剂的研发,用于药物的控释。
Materials (Basel). 2021 Feb 18;14(4):963. doi: 10.3390/ma14040963.
2
Development of Novel Silica-based Formulation of α-Lipoic Acid: Evaluation of Photo and Thermal Stability of the Encapsulated Drug.新型基于二氧化硅的α-硫辛酸制剂的研发:对包封药物的光稳定性和热稳定性的评估
Pharmaceutics. 2020 Mar 4;12(3):228. doi: 10.3390/pharmaceutics12030228.
3
Design of silica carrier for controlled release of molsidomine: effect of preparation methods of silica matrixes and their composites with molsidomine on the drug release kinetics in vitro.用于莫西多明控释的二氧化硅载体设计:二氧化硅基质及其与莫西多明复合材料的制备方法对体外药物释放动力学的影响。
Eur J Pharm Biopharm. 2014 Nov;88(3):1038-45. doi: 10.1016/j.ejpb.2014.09.007. Epub 2014 Sep 28.
4
Development of Novel Warfarin-Silica Composite for Controlled Drug Release.用于控释药物的新型华法林-二氧化硅复合材料的研发。
Pharm Res. 2017 Apr;34(4):825-835. doi: 10.1007/s11095-017-2111-9. Epub 2017 Jan 30.
5
Effects of synthesis conditions and release medium pH on release properties of acyclovir - mercaptopropyl modified silica composite.合成条件和释放介质 pH 值对阿昔洛韦-巯基丙基改性硅胶复合材料释放性能的影响。
Drug Dev Ind Pharm. 2021 Oct;47(10):1624-1632. doi: 10.1080/03639045.2022.2037627. Epub 2022 Feb 7.
6
Sol-gel Derived Warfarin - Silica Composites for Controlled Drug Release.溶胶-凝胶法制备的用于控释的华法林-二氧化硅复合材料
Curr Drug Deliv. 2017;14(5):734-740. doi: 10.2174/1567201813666161021103714.
7
Development of Novel Delivery System for Cardiovascular Drug Molsidomine: Influence of Synthesis Method and Conditions on Molsidomine Release From Its Composites With Hydrophilic Silica In Vitro.心血管药物吗多明新型给药系统的研发:合成方法和条件对吗多明与亲水性二氧化硅复合材料体外释放的影响
J Pharm Sci. 2016 Jun;105(6):1952-1959. doi: 10.1016/j.xphs.2016.03.042.
8
Preparation of mesoporous silica microparticles by sol-gel/emulsion route for protein release.介孔硅微球的溶胶-凝胶/乳液法制备及其蛋白质释放。
Pharm Dev Technol. 2019 Feb;24(2):243-252. doi: 10.1080/10837450.2018.1457051. Epub 2018 Apr 6.
9
Effect of synthesis parameters of the sol-gel-processed spray-dried silica gel microparticles on the release rate of dexmedetomidine.溶胶-凝胶法制备的喷雾干燥硅胶微粒合成参数对右美托咪定释放速率的影响
Biomaterials. 2002 Jul;23(13):2795-801. doi: 10.1016/s0142-9612(02)00016-9.
10
Development of pH-responsive biopolymer-silica composites loaded with Larrea divaricata Cav. extract with antioxidant activity.载有具有抗氧化活性的 Larrea divaricata Cav. 提取物的 pH 响应性生物聚合物-硅酸钠复合材料的开发。
Colloids Surf B Biointerfaces. 2018 Sep 1;169:82-91. doi: 10.1016/j.colsurfb.2018.05.015. Epub 2018 May 7.

引用本文的文献

1
Nanotechnological Approaches to Enhance the Potential of α-Lipoic Acid for Application in the Clinic.增强α-硫辛酸临床应用潜力的纳米技术方法。
Antioxidants (Basel). 2024 Jun 9;13(6):706. doi: 10.3390/antiox13060706.

本文引用的文献

1
Development of Novel Silica-based Formulation of α-Lipoic Acid: Evaluation of Photo and Thermal Stability of the Encapsulated Drug.新型基于二氧化硅的α-硫辛酸制剂的研发:对包封药物的光稳定性和热稳定性的评估
Pharmaceutics. 2020 Mar 4;12(3):228. doi: 10.3390/pharmaceutics12030228.
2
Control-released Alpha-lipoic acid-loaded PLGA microspheres enhance bone formation in type 2 diabetic rat model.控释α-硫辛酸负载聚乳酸-羟基乙酸共聚物微球增强2型糖尿病大鼠模型的骨形成
Int J Clin Exp Pathol. 2017 Sep 1;10(9):10019-10031. eCollection 2017.
3
Insights on the Use of α-Lipoic Acid for Therapeutic Purposes.
α-硫辛酸用于治疗目的的相关见解。
Biomolecules. 2019 Aug 9;9(8):356. doi: 10.3390/biom9080356.
4
Release Profile of Gentamicin Sulfate from Polylactide--Polycaprolactone Electrospun Nanofiber Matrices.硫酸庆大霉素从聚丙交酯-聚己内酯电纺纳米纤维基质中的释放曲线
Pharmaceutics. 2019 Apr 3;11(4):161. doi: 10.3390/pharmaceutics11040161.
5
pH Effect and Chemical Mechanisms of Antioxidant Higenamine.pH 效应与抗氧化剂盐酸育亨宾的化学机制。
Molecules. 2018 Aug 29;23(9):2176. doi: 10.3390/molecules23092176.
6
Oxidative stress, aging, and diseases.氧化应激、衰老和疾病。
Clin Interv Aging. 2018 Apr 26;13:757-772. doi: 10.2147/CIA.S158513. eCollection 2018.
7
Alpha lipoic acid intoxicatıon: An adult.硫辛酸中毒:成人病例。
Am J Emerg Med. 2018 Jun;36(6):1125.e3-1125.e5. doi: 10.1016/j.ajem.2018.03.022. Epub 2018 Mar 13.
8
In vitro evaluation of α-lipoic acid-loaded lipid nanocapsules for topical delivery.载硫辛酸的脂质纳米胶囊经皮给药的体外评价。
J Microencapsul. 2017 Sep;34(6):571-581. doi: 10.1080/02652048.2017.1367852. Epub 2017 Sep 3.
9
Determination of pH-dependent antioxidant activity of palm (Borassus flabellifer) polyphenol compounds by photoluminol and DPPH methods: a comparison of redox reaction sensitivity.通过光致鲁米诺和DPPH方法测定棕榈(扇叶树头榈)多酚化合物的pH依赖性抗氧化活性:氧化还原反应敏感性比较
3 Biotech. 2015 Oct;5(5):633-640. doi: 10.1007/s13205-014-0260-7. Epub 2014 Oct 19.
10
CVD and Oxidative Stress.心血管疾病与氧化应激
J Clin Med. 2017 Feb 20;6(2):22. doi: 10.3390/jcm6020022.